Summary
Photodynamic virus inactivation of human fresh plasma mediated by visible light in the presence of the phenothiazine dyes methylene blue or toluidine blue was investigated to determine whether it influences functional, structural, and immunological properties of plasma proteins. The activities of the coagulation factors I, VIII, IX, X, and XI were affected to a certain degree, while those of most other plasma proteins were not. The elution profiles obtained by ion exchange chromatography of untreated and photodynamically treated plasma were almost identical. Using a number of antisera against human plasma and single plasma proteins, different immunochemical techniques revealed identical patterns for untreated and treated plasma. Thus, there was no indication that the photodynamic virus inactivation procedure applied considerably influences the properties of plasma proteins.
Similar content being viewed by others
References
Alter HJ, Morel PA, Dorman BP, Smith GC, Creagan RP, Wiesehahn GP, Corash L, Popper H, Eichberg JW (1988) Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus. Lancet 8627: 1446–1450
Aronson DL, Menaché MD (1987) Prevention of infectious disease transmission by blood and blood products. Prog Haematol 15: 221–241
Clarke MHG, Freeman T (1968) Quantitative immunoelectrophoresis of human serum proteins. Clin Sci 35: 403–413
Clauss A von (1957) A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol 17: 237–246
Daunderer M (1980) Antidot-Therapie: Toluidinblau bei Methämoglobinämie. Fortschr Med 98: 462–464
Edwards CA, Piet MPJ, Chin S, Horowitz B (1987) Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives. Vox Sang 52: 53–59
Fratanoni JC, Prodouz KN (1990) Viral inactivation of blood products. Transfusion 30: 480–481
Fujii Y, Kobashi K, Nakai N (1984) Photo-oxidation of histidine residues in rat M1- and L-type pyruvate kinases. J Biochem 95: 1289–1296
Gellis SS, Neefe JR, Stokes J jr, Strong LE, Janewy CA, Scatchard G (1947) Chemical, clinical and immunological studies on the products of human plasma fractionation: 36. Inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat. J Clin Invest 27: 239–244
Heimburger H, Schwinn H, Mauler R (1980) Factor VIII concentrate, hepatitis safe: progress in the treatment of hemophilia. Die gelben Hefte 20: 165–174
Hiatt CW (1972) Methods for photoinactivation of viruses. In: Concepts in radiation cell biology. Academic, New York, pp 57–82
Hiatt CW, Kaufman E, Helprin JE, Baron S (1960) Inactivation of viruses by the photodynamic action of toluidine blue. J Immunol 84: 480–484
Hollinger FB, Dolana G, Thomas W, Gyorkey F (1984) Reduction in risk of hepatitis transmission by heat treatment of human factor VIII concentrate. J Infect Dis 150: 250–262
Horowitz B, Wiebe ME, Lippin A, Stryker MH (1985) Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 25: 516–522
Inada Y, Hessel B, Blombaeck B (1977) Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochim Biophys Acta 532: 161–170
Kiese M, Loercher W, Weger N, Zierer A (1972) Comparative studies on the effects of toluidine blue and methylene blue on the reduction of ferrihaemoglobin in man and dog. Eur J Clin Pharmacol 4: 115–118
Lambrecht B, Mohr H, Knüver-Hopf J, Schmitt H (1991) Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 60: 207–213
Lewin AA, Schnipper LE, Crumpacker CS (1980) Photodynamic inactivation of Herpes simplex virus by hematoporphyrin derivative and light. Proc Soc Exp Biol Med 163: 81–90
Mathews JL, Newman JT, Sogandares-Bernal F, Judy MM, Skiles H, Leveson JE, Marengo-Rowe AJ, Chanh TC (1988) Photodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion 28: 81–83
Naylor GJ, Martin B, Hopwood SE, Watson Y (1986) A two-year double-blind cross-over trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry 21: 915–920
Neyendorff HC, Bartel DL, Levy JG (1990) Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion 30: 485–490
O'Brien JM, Montgomery RR, Burns WH, Gaffney DK, Sieber F (1990) Evaluation of merocyanine-540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med 116: 439–447
Osterloh J, Olson K (1986) Toxicities of alkyl nitrites. Ann Intern Med 104: 727
Ouchterlony Ö (1962) Diffusion-in-gel methods for immunological analysis. II. Prog Allergy 6: 30–154
Stephan W (1982) Fractionation of cold sterilized plasma. A new concept of production of non-infectious plasma proteins. Arzneimittelforschung 32: 799–801
Wallis G, Melnick JL (1964) Irreversible photosensitization of viruses. Virology 23: 520–527
Wallis C, Melnick JL (1965) Photodynamic inactivation of animal viruses: a review. Photochem Photobiol 4: 159–170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mohr, H., Knüver-Hopf, J., Lambrecht, B. et al. No evidence for neoantigens in human plasma after photochemical virus inactivation. Ann Hematol 65, 224–228 (1992). https://doi.org/10.1007/BF01703949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01703949